M&A Deal Summary |
|
|---|---|
| Date | 2020-09-01 |
| Target | Bayer AG - Profender and Drontal Products |
| Sector | Food |
| Buyer(s) | Vetoquinol |
| Sellers(s) | Bayer |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1933 |
| Sector | Life Science |
| Employees | 2,437 |
| Revenue | 539M EUR (2024) |
Vetoquinol is a veterinary pharmaceutical company. Vetoquinol was founded in 1933 and is based in Lure, France.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector: Food M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: Germany M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-03 |
Clarion Biociencias
Goiania, Brazil Clarion Biociencias Ltda. is a veterinary laboratory based in the state of Goiás. Clarion Biociencias Ltda. employs around 180 people and has a state-of-the-art production facility. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1863 |
| Sector | Life Science |
| Employees | 89,556 |
| Revenue | 46.6B EUR (2024) |
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 15 of 23 |
| Sector: Food M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 11 of 19 |
| Country: Germany M&A | 10 of 12 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-11 |
KaNDy Therapeutics
Stevenage, United Kingdom KaNDy Therapeutics is a private clinical-stage biotech based at the state-of-the-art Stevenage Bioscience Catalyst, a leading location for companies to develop and commercialize cutting edge therapeutics. KaNDy Therapeutics was formed in 2017 and is based in Stevenage, United Kingdom. |
Buy | $425M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-26 |
AskBio
Research Triangle Park, North Carolina, United States Asklepios BioPharmaceutical, Inc. is a clinical-stage gene therapy platform company dedicated to improving the lives of children and adults with rare genetic disorders. AskBio’s gene therapy platform includes an industry-leading proprietary cell line manufacturing process known as Pro10TM and an extensive AAV capsid library. AskBio maintains a portfolio of clinical programs across a range of indications including Pompe, Limb-Girdle Muscular Dystrophy, Cystic Fibrosis, Myotonic Muscular Dystrophy, Hemophilia (Chatham Therapeutic/Takeda) and Duchenne Muscular Dystrophy (Bamboo Therapeutics/Pfizer). AskBio was established in 2001 and is based in Research Triangle Park, North Carolina. |
Buy | $2.0B |
